Related Experiment Videos
Systemic treatment of non-small-cell lung cancer
R Lenzi1, F V Fossella, J S Lee
1Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Comprehensive Therapy
|March 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Lymph node micrometastases in non small-cell lung cancer: clinical applications.
Clinical lung cancer·2004
ZD1839 (Iressa) in non-small-cell lung cancer.
Clinical lung cancer·2003
Emerging therapies in non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2001
Second-line chemotherapy for non-small-cell lung cancer.
Current oncology reports·2000
Heparin-induced thrombocytopenia and thrombosis.
Comprehensive therapy·2011
Antiplatelet therapy in cardiovascular disease.
Comprehensive therapy·2011
Genetics of cardiovascular disease.
Comprehensive therapy·2011
Septic renal vein thrombosis complicated by septic pulmonary embolism.
Comprehensive therapy·2011
Gout and hyperuricemia.
Comprehensive therapy·2011
Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.
Comprehensive therapy·2010
Post-diagnosis cannabis use and its association with health status and quality of life in cancer survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Aloesin mitigates cisplatin-induced nephrotoxicity by suppressing NF-κB-mediated oxidative stress and modulating Bax/Bcl-2/caspase pathways.
Naunyn-Schmiedeberg's archives of pharmacology·2026